23 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp02017 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | U-251 | Brain tumor | IC50 : 10.6 µg/ml |
| dbacp03521 | Kassiniatuerin-3 | FIQHLIPLIPHAIQGIKDIF | Senegal running frog, Africa | Membranolytic mechanism | MTT assay | U-251 MG | Glioblastoma (astrocytoma) | IC50 : 13.20 µM |
| dbacp04362 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | U-251 | Brain tumor | IC50 : 17.0 µM |
| dbacp06337 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | U-251 | Brain tumor | IC50 :7.0 µM |
| dbacp06671 | Crabrolin | FLPLILRKIVTAL | European hornet (Vespa crabro) | Not available | MTT assay | U-251-MG | Brain Tumor | IC50 = 20.13 μM |
| dbacp06676 | Crabrolin-4R | FLPRILRKIVTAL | Synthetic Analog of Crabrolin | Not available | MTT assay | U-251-MG | Brain Tumor | IC50 = 25.09 μM |
| dbacp06681 | Crabrolin-4K | FLPKILRKIVTAL | Synthetic Analog of Crabrolin | Not available | MTT assay | U-251-MG | Brain Tumor | IC50 = 23.51 μM |
| dbacp06686 | Crabrolin-TR | FLPRILRKIVRAL | Synthetic Analog of Crabrolin | Not available | MTT assay | U-251-MG | Brain Tumor | IC50 = 12.40 μM |
| dbacp06691 | Crabrolin-FR | RLPRILRKIVRAL | Synthetic Analog of Crabrolin | Not available | MTT assay | U-251-MG | Brain Tumor | IC50 = 62.17 μM |
| dbacp06696 | Crabrolin-AR | RLPRILRKIVRRL | Synthetic Analog of Crabrolin | Not available | MTT assay | U-251-MG | Brain Tumor | IC50 = 52.01 μM |
| dbacp06701 | Crabrolin-PR | RLRRILRKIVRRL | Synthetic Analog of Crabrolin | Not available | MTT assay | U-251-MG | Brain Tumor | IC50 = 17.70 μM |
| dbacp06769 | M1-21 | rrrqrrkkrg-QTQPRLGPPQTPAGGCSILIF | Synthetic | FOXM1 inhibitor | Cell Viability assay | U-251 | BrainTumor | IC50 = 18.17 µM |
| dbacp07006 | ST101 | vaeareelerlearlgqargelkkwkmrrnqfwlklqr | Synthetic | Prevents C/EBPβ dimerization, induces degradation | Annexin V/ PI staining assay | U-251 | Brain Tumor | mean EC50 value of 2.1 ± 0.4 μmol/L |
| dbacp07109 | Nigrocin-M1 | GLLGKILGAGKKVLLGVSGLL | Synthetic | Membrane disruption mediates selective cytotoxicity. | MTT assay | U-251-MG | Brain Tumor | IC50 = 25.06 μM |
| dbacp07247 | ATX-101 | MDRWLVKWKKKRKIRRRRRRRRRRR | Synthetic | PCNA interference disrupts DNA repair. | CCK-8 assay | U-251 | Brain Tumor | IC50 = 4.9 ± 0.3 μM |
| dbacp07515 | Dermaseptin-PP | ALWKDMLKGIGKLAGKAALGAVKTLV | Phyllomedusa palliata | Membrane disruption triggers dual apoptosis | MTT assay | U-251 | Brain Tumor | IC50 = 2.47 μM |
| dbacp07954 | S-24-R2PLx | GIMDTVKNAAKNLAGQLLDKLKCSITAC | Synthetic Analogue of Ranatuerin-2PLx | R2PLx induces caspase-dependent apoptosis | MTT assay | U-251-MG | Brain Tumor | IC50 = 278.30 µM |
| dbacp08022 | Peptide4 Gonearrestide | ADAPGNYPLDARGKSYYC | Androctonus australis | Gonearrestide induces G1 cell-cycle arrest | MTT assay | U-251 | Brain tumor | Not Available |
| dbacp08027 | Peptide6 Gonearrestide | KLSAIISKIRDE | Androctonus australis | Gonearrestide induces G1 cell-cycle arrest | MTT assay | U-251 | Brain tumor | Not Available |
| dbacp08032 | Peptide10 Gonearrestide | NDADKDEMQSVYRGKANDDNSRGSKTNHRF | Androctonus mauritanicus | Gonearrestide induces G1 cell-cycle arrest | MTT assay | U-251 | Brain tumor | Not Available |
| dbacp08037 | Peptide13 Gonearrestide | WCYKLPDRVSIKEKGRCN | Androctonus mauritanicus | Gonearrestide induces G1 cell-cycle arrest | MTT assay | U-251 | Brain tumor | Not Available |
| dbacp08294 | CA4 | CGPCFTTDHNMARKCDECCGGKGRGKCFGPQCLCR | Synthetic | Not Available | MTT assay | U-251 | Brain Tumor | Graph Figure 2 |
| dbacp08295 | CTX-23 | VCMPCFTTDQQMARKCSDCCGGKGRGKCYGPQCLCR | Synthetic | Not Available | MTT assay | U-251 | Brain Tumor | Graph Figure 2 |